Literature DB >> 6236013

Enumeration of T-lymphocytes and T-lymphocyte subsets in rheumatoid arthritis using monoclonal antibodies.

F Raeman, W De Cock, T De Beukelaar, J Leempoels, J De Cree, H Verhaegen.   

Abstract

The number of T-lymphocytes and T-lymphocyte subsets was measured in peripheral blood of 51 patients with rheumatoid arthritis. T-lymphocytes were counted by E-rosette tests and by the immunogold staining method with OKT3.PAN monoclonal antibody. Helper and suppressor T-lymphocytes were determined by the immunogold staining method with OKT4.IND and OKT8.SUP monoclonal antibody. The relative and absolute numbers of T-lymphocytes and helper T-lymphocytes in peripheral blood of patients with RA did not differ significantly from those in the blood of healthy subjects. However, the relative and absolute numbers of suppressor T-cells were significantly lower in patients with RA than in healthy subjects. The decrease of suppressor T-cells in the blood of patients with RA dit not correlate with the activity of the disease nor the presence of the rheumatoid factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6236013     DOI: 10.1007/bf02042774

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Altered function of suppressor T lymphocytes in patients with active systemic lupus erythematosus--in vitro immune response to autoantigen.

Authors:  C Morimoto; T Abe; M Homma
Journal:  Clin Immunol Immunopathol       Date:  1979-06

2.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

3.  Immunoregulatory aberrations in systemic lupus erythematosus.

Authors:  A S Fauci; A D Steinberg; B F Haynes; G Whalen
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

4.  Defective suppressor T-cell activity in systemic lupus erythematosus.

Authors:  D B Kaufman; E Bostwick
Journal:  Clin Immunol Immunopathol       Date:  1979-05

5.  Enumeration of T lymphocytes subsets in autoimmune disease using monoclonal antibodies.

Authors:  F Raeman; W De Cock; T De Beukelaar; J De Cree; H Verhaegen
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

6.  Enumeration of human peripheral T lymphocytes with E-rosettes and OKT3. PAN monoclonal antibody: a close correlation.

Authors:  W de Cock; J de Cree; H Verhaegen
Journal:  Thymus       Date:  1980-12

7.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  Deficit of suppressor T cells in active multiple sclerosis.

Authors:  M A Bach; F Phan-Dinh-Tuy; E Tournier; L Chatenoud; J F Bach; C Martin; J D Degos
Journal:  Lancet       Date:  1980-12-06       Impact factor: 79.321

10.  Loss of suppressor T cells in adult NZB/NZW mice.

Authors:  R S Krakauer; T A Waldmann; W Strober
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

View more
  3 in total

1.  Decreased tissue immunoregulatory index in rheumatoid synovitis, determined by in-situ T-cell phenotyping with monoclonal antibodies.

Authors:  R Dreher
Journal:  Agents Actions       Date:  1986-12

2.  Transferrin receptor bearing cells in the peripheral blood of patients with rheumatoid arthritis.

Authors:  M Salmon; P A Bacon; D P Symmons; A D Blann
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

3.  Eluted rheumatoid synovial tissue T cell subsets and HLA-DR bearing cells at different stages of fractionation.

Authors:  T Egeland; O Førre
Journal:  Clin Rheumatol       Date:  1983-03       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.